These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7984980)

  • 1. Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine.
    Struve J; Aronsson B; Frenning B; Forsgren M; Weiland O
    Scand J Infect Dis; 1994; 26(4):468-70. PubMed ID: 7984980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine.
    Struve J; Aronsson B; Frenning B; Forsgren M; Weiland O
    Infection; 1995; 23(1):42-5. PubMed ID: 7744490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders.
    Goldwater PN
    Vaccine; 1997 Mar; 15(4):353-6. PubMed ID: 9141204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to intramuscular revaccination after primary intradermal vaccination against hepatitis B.
    Pegues DA; Woodruff BA; Lambert SB; Tant MK; Woernle CH
    Clin Infect Dis; 1995 Feb; 20(2):335-41. PubMed ID: 7742439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response.
    Struve J; Aronsson B; Frenning B; Granath F; von Sydow M; Weiland O
    Scand J Infect Dis; 1992; 24(4):423-9. PubMed ID: 1411307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine.
    Waite NM; Thomson LG; Goldstein MB
    J Am Soc Nephrol; 1995 May; 5(11):1930-4. PubMed ID: 7620090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
    Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
    el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
    Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. I. Seroconversion rate and adverse effects.
    Baldy JL; Elisbão Mdo C; Anzai ET; Pontello R; Reiche EM; Zaha-Inouye MM; Matsuo T; Tonani PC; Ferelle A; Henriques JN; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1101-7. PubMed ID: 15049098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative efficacy of intradermal and intramuscular active immunization against hepatitis B with a recombinant vaccine. Preliminary results].
    Torres JR; de Marquez ML; Gonzalez A; Ramirez V; Martinez N; Lecuna V
    G E N; 1993; 47(3):145-9. PubMed ID: 8112550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders.
    Goldwater PN
    Vaccine; 1994 Apr; 12(5):410-4. PubMed ID: 8023548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs).
    Ghebrehewet S; Baxter D; Falconer M; Paver K
    Hum Vaccin; 2008; 4(4):280-5. PubMed ID: 18398298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
    Das HS; Sawant P; Shirhatti RG; Vyas K; Vispute S; Dhadphale S; Patrawalla V; Desai N
    Trop Gastroenterol; 2002; 23(3):120-1. PubMed ID: 12693152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation.
    Duca P; Del Pont JM; D'Agostino D
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):168-70. PubMed ID: 11321387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff.
    Tele SA; Martins RM; Lopes CL; dos Santos Carneiro MA; Souza KP; Yoshida CF
    Eur J Epidemiol; 2001; 17(2):145-9. PubMed ID: 11599688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-HBs response after 2 different accelerated intradermal and intramuscular schemes for hepatitis B vaccination.
    Carlsson T; Struve J; Sönnerborg A; Weiland O
    Scand J Infect Dis; 1999; 31(1):93-5. PubMed ID: 10381226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.